Topical anti-inflammatory drug therapy

Abstract From the Canadian patent

A pharmaceutical composition for topical treatment of cutameous disorders or disruptions characterized by skin inflammation or hyperproliferative epidermal activity comprises the combination of a topically active anti-inflammatory corticosteroid and a non-steroidal anti-inflammatory agent which is an inhibitor of prostaglandin synthetase selected from the group consisting of the hydratropic acid derivations; acetylsalicylic acid; the pyrazolonedericativen; the fenamic acid derivatives; the aroyl-substituted pyrroles and the substituted arylacetohydroxamic acids in a pharmaceutically acceptiable topical vehicle. Treatment of above cutaneous disorders may also be effected by concurrent …